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ABSTRACT.Recently we described a protein, smoothelin, that has been exclusively found in smooth muscle
cells (SMC). The humanCDNAhas been cloned from a colon CDNAlibrary and the putative protein sequence
was deduced. Smoothelin does not belong to a known protein family but shows a partial homology with mem-
bers of the spectrin family. Transfection studies revealed that smoothelin has an affinity for actin and is either
capable of forming filamentous structures or colocalizes with such structures. The protein is expressed in
visceral as well as vascular tissues of all vertebrate classes. A study on the distribution of smoothelin in the vascu-
lar and placental system showed that smoothelin expression was largely restricted to the muscular pulsating
blood vessels. Therefore, we hypothesized that smoothelin is expressed in contractile SMConly (36, 37).
Noexpression of smoothelin was observed in established cell lines of SMC.In tissue explants smoothelin
inRNAconcentration decreases to undetectable levels within 12 hours after dissection as was in general the case
in primary cell cultures. Here we report on continued smoothelin expression for several passages observed in a
human prostate primary cell culture system. Smoothelin was demonstrated to colocalize with actin stress fibers
but not with desmin filaments. This culture system offers opportunities to study the cytological localization of
smoothelin, interactions with other proteins and should provide a system to test the promoter of the smoothelin
gene. On immunoblots the molecular weight of smoothelin differed between visceral and vascular smooth mus-
cle tissue with apparent molecular weights of respectively 59 kDa and 94 kDa. There is no evidence for the exist-
ence of another gene coding for the 94 kDa smoothelin. Thus, posttranslational modification, alternative splic-
ing and dual promoter control are the alternatives for the expression of two isoforms of smoothelin.
Smooth muscle cells (SMC) are found in those organs
that are involved in basic physiological functions such
as breathing, reproduction and transport of nutrients
and oxygen. Although SMCappear more 'primitive' in
organization and differentiation, as compared to stri-
ated (cardiac and skeletal) muscle cells, they developed
simultaneously during evolution (13, 23). Skeletal and
cardiac muscle are referred to as striated muscle be-
cause of their conspicious transverse striations showing
the high level of organization of actin and myosin fila-
ments in the myofibers. On the other hand, in SMCac-
tin and myosin filaments have a less ordered organiza-
tion that has still to be clearly defined. Both striated
muscle cell types have a terminal differentiation, i.e.
once they become a skeletal or a heart muscle cell they
will, under physiological conditions, not return to a pre-
vious differentiation stage. In contrary, SMCcan shut-
tie between a contractile and a synthetic/proliferative
phenotype, a process called modulation (4, 5). During
embryogenesis striated muscle cells differentiate and mi-
grate according to well denned developmental pathways
whereas the embryological origin of smooth muscle
cells appears to be diverse and is still a matter of debate(15, 16). SMCaligning the digestive and genital tracts
appear to be derived from the mesodermal plate where-
as SMCof the vascular system are suggested to be re-
cruited from the surroundings of the blood vessels and
to differentiate into SMCunder the influence of factors
secreted by endothelial cells (38).
One reason for the relatively poor understanding of
SMCbiology is the lack of markers indicative for the
phenotypes of these cells and/or for their embryologi-
cal origin. A number of proteins, such as calponin,
metavinculin and a-smooth muscle actin, have been sug-
gested as markers for SMC (7, 10, ll, 12, 14, 19, 31,
33). However, they are also found in other tissues dur-
ing embryonic development and in certain pathological
conditions (1, 2, 3, 22, 25, 34, 35). The protein that can
be qualified as most SMCspecific is the smooth muscle
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myosin heavy chain isoforms SMI and SM2 (21, 26).
These proteins are found only in SMC and are ex-
pressed relatively late during ontogenesis. As stated by
Owens (26) "It is critical to distinguish proteins that are
characteristic of a given stage (or state) of SMCdifferen-
tiation/maturation versus proteins that alone can serve
as definitive markers for identification of SMClineages
to the exclusion of all other cell types". Recently, we de-
scribed the detection and characterization of a smooth
muscle specific protein, smoothelin (36, 37). We hypoth-
esized that the protein might be specific for the contrac-
tile phenotype of SMC.This hypothesis was based on
four characteristics of smoothelin.
1) The absence of the protein in cultured SMC.No
smoothelin was found in the SMClines and the primary
cultures of SMCtested. This might be due to selection(only proliferative SMCwill continue to grow in cul-
ture) or to dedifferentiation (contractile SMCrevert to
the proliferative SMC).
2) The decline of smoothelin transcription in tissue ex-
plants. It was found that smoothelin mRNAdisappears
within 12 hours after dissection of the smooth muscle
tissue (36).
3) The distribution of smoothelin in the vascular sys-
tem. The smoothelin content of a variety of blood
vessels in adults and during vasculogenesis of the placen-
ta was investigated by immunofluorescence and immu-
noblotting. Smoothelin concentrations paralleled the
contractility of the vessels (37).
4) The affinity of smoothelin for actin. Since actin is
one of the major componentsof the contractile machin-
ery, the affinity of smoothelin might indicate a function
in the contractile apparatus of SMC.
These data suggested that smoothelin is a marker for
SMCof the contractile type and as such for the final
differentiation stage of SMC.
In this paper we summarize the present knowledge
about smoothelin and demonstrate its suitebility as a
late differentiation marker, i.e. a marker for SMCof
the contractile phenotype. A cell culture system is pre-
sented which maintains smoothelin synthesis. In addi-
tion, we show that a vascular-specific form of smoothe-
lin occurs. The excistence of the two isoforms may pro-
vide some insight in the differences between vascular
and visceral SMC.
MATERIALS AND METHODS
Tissue samples. Normal adult humantissues, obtained at
autopsy, were immediately frozen in liquid nitrogen and
stored at -80°C until use. Tissues from animals (pig, dog,
rabbit, rat, mouse) were dissected within a few minutes and
immediately frozen in liquid nitrogen. Smooth muscle cells
from human vena, human uterine and mammaryartery,
humanprostate and neonatal chicken gizzard were obtained
by enzymatic dispersion (collagenase/pancreatin: Life Tech-
nologies, Gaithesburg, MD, USA). For immunohistochemis-
try tissues were mounted in Tissue-Tek (OCT-compound;
Miles Inc. Elkhart, IN, USA), and 3 to 5 fim thick sections
were cut at -25°C and air-dried overnight at room tempera-
ture or immediately fixed with methanol (at -20°C for 5 min)
followed by acetone (-20°C for 30 sec) and airdried for 3
hours before use. Cultured cells were grownon microscopic
cover slips and fixed by shortly dipping in methanol/acetone
at -20°C.
Culture of prostate epithelial cells. Fresh transuretherally
resected prostatic tissue from benign prostate hyperplasia
patients was cut into 1-2mm3 pieces and spread in a 25
cm2 flask. Fragments were allowed to adhere to the plastic
substrate and covered with 2ml of 'collection medium'
[Dulbecco's Modified Essential Medium supplemented with
20% fetal calf serum, penicillin (100 U/ml), streptomycin
(100 //g/ml) and amphotericin (2.5 //g/ml), all purchased
from Life Technologies]. Explants were allowed to settle for
at least 96 hours, then mediumwas changed twice a week.
Whencells started to migrate out of the tissue fragments 'col-
lection medium' was replaced by 'smooth muscle specific medi-
um' [MDCB-131medium supplemented with 15% horse se-
rum, 10 mMHepes pH 7.2, 2% penicillin/streptomycin, 2%
MEM-Eagle's solution of non-essential amino acids (all Life
Technologies, Gaithesburg, MD), 5 ^g/ml insulin, 10 ^g/ml
transferrin, 5 ng/ml sodium selenite, 0.1 ^M estradiol, 0.1
[i% dexamethasone (all from Sigma, St. Louis, MO)]. The
'smooth muscle specific medium' was mixed with conditioned
mediumfrom cell line LNCAPat a ratio 3:1. The conditioned
LNCAPmediumwas obtained by growing the cells in base me-
dium (MDCB-131, 15% horse serum, 10mM Hepes pH 7.2,
2% MEMEagle's solution of non-essential amino acids) for
3-5 days. Mediumwas separated from the cells by filtration
and was stored at 4°C until use. Prostatic cell cultures were
maintained in an atmosphere of 5% CO2/95% humidified air.
Every 2-3 days the mediumwas replaced. Once the cells had
reached con fluency they were trypsinized and transfered to
fresh flasks in a 1:5 dilution.
Antibodies. Antibodies used in this study were:
1. The mouse monoclonal antibody R4A directed against
smoothelin (36).
2. Polyclonal rabbit antiserum (pDes) to chicken gizzard des-
min (27).
3. Monoclonalantibody sm-1 to smooth muscle actin was
purchased from Sigma Immuno Chemicals (St. Louis,
MO, USA) (31).
4. Affinity purified rabbit antiserum (pKer), directed against
keratin and purchased from Euro-Diagnostics (Apel-
doom, The Netherlands) (28).
In addition, rhodamine-labeled phalloidin (purchased from
Molecular Probes Inc. Eugene, OR, USA) was used to stain
actin stress-fibers.
Immunohistochemistry. For immunofluorescence 3 to 5
//m thick cryostat sections were pretreated for 5 min with
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0.5% Triton X-100 (BDH Chemicals Ltd., Poole, UK) in
phosphate buffered saline (PBS: 137mM NaCl, 13mM
Na2HPO4-2H2O, 3 mMKH2PO4 pH 7.4; Merck, Darmstadt,
Germany), followed by a PBS washing step for 5 min. Metha-
nol/acetone fixed sections and fixed cells were used without
Triton X- 100-pretreatment.
Fixed cells or tissue sections were incubated with the pri-
mary antibody for 30 min at room temperature, washed with
PBS and incubated with a secondary antibody conjugated to
either fluorescein isothiocyanate (FITC) (goat anti-mouse-
IgG-FITC, Southern Biotechnology Associates Inc., Birmin-
gham, AL, USA), or Texas Red (TR) (goat anti-rabbit-Ig-TR
/goat anti-mouse-IgGl-TR; SBA), or horseradish peroxidase(peroxidase-conjugated rabbit anti-mouse; DAKOA/S, Co-
penhagen, Denmark). Incubations with secondary antibodies
were performed for 30 min at room temperature. Peroxidase
activity was demonstrated with 4-amino-9-ethylcarbazole
(AEC; Aldrich Chemical Company, St. Louis, MO, USA).
After three washing steps with PBS, the fluorescently stained
tissues were mounted in Mowiol (Hoechst, Frankfurt, FRG)
or, for AEC stained sections, in Kaiser's glycerin-gelatin
(Merck).
Protein gel electrophoresis and Western blotting. Approx-
imately 40 cryostat sections (each 20 ftm thick) of fresh frozen
tissues or about 106 cultured cells were collected, washed with
1 ml PBS and centrifuged for 5 min at 12.000xg. After cen-
trifugation the pellet was subjected to a Triton X-100 extrac-
tion step and after a PBS wash suspended in 1% Triton X-
100, 5 mMethylene-diamino-tetra-acetic acid disodium salt di-
hydrate (EDTA; Merck), 0.4 mMphenylmethylsulfonyl fluo-
ride (PMSF; Merck) in PBS, pH 7.4 (36), and extracted for 5
min on ice. After centrifugation for 5 min at 12.000xg, the
pellet was washed in 1 ml PBS. After a final centrifugation
step (5 min, 12.000 x g), the cytoskeletal preparation was dis-
solved by boiling for 4 min in sample buffer (18), containing
2.3% sodium dodecylsulfate (SDS) and 5% /3-mercaptoetha-
nol (Bio-Rad Laboratories, Richmond, CA, USA).
For one-dimensional SDS-polyacrylamide gel electrophore-
sis (SDS-PAGE) using a Mini Protean II Electrophoresis Cell
(Bio-Rad Laboratories) 7.5-10% polyacrylamide slab gels con-
taining 0. 1% SDS (18) were used. After electrophoretic separa-
tion, the proteins were stained with Page Blue 83 (BDHChem-
icals Ltd.) or subjected to Western blotting. Culture superna-
tant of monoclonal antibody R4Adirected against smoothelin
was used in a 1 :5 dilution and immunodetection with horserad-
ish peroxidase conjugated rabbit anti-mouse-Ig (DAKOA/S)
was performed according to standard procedures.
Southern blot analysis. Total nuclear humanDNAwas
isolated from peripheral white blood cells by phenol extrac-
tion according to standard procedures (30). DNAwas restric-
tion digested and transferred to HiBond (Amersham, UK)(32). Filters were hybridized with 50-200 ng of smoothelin
CDNAprobe labeled with [a-32P]dATP by random priming
(9) at a temperature of 60°C (6). Filters were washed at a final
stringency of 0.1 SSC/0.1% SDS at 60°C.
In situ hybridization. The probe used for chromosome 22
identification has been described by Kurahashi and coworkers
(17). Probe labeling and fluorescent in situ hybridizations
(FISH) was carried out as described previously (8). FISH with
probe CHKAD-25, specific for chromosome region 22q23-
22qter (17) were performed simultaneously with a smoothelin
cosmid probe.
RESULTS
Characteristics of the two isoforms of smoothelin.
Sections of different smooth muscle tissues from a num-
ber of species were incubated with antibody R4A. SMC
of the visceral tissues, the urogenital tract and the vascu-
lar system reacted all with monoclonal antibody R4A in
immunofluorescence microscopy (Fig. 1). In all these
tissues R4Apositive SMCdisplayed a strong cytoplas-
mic staining. However, in immunoblotting a clear differ-
ence was revealed between visceral/urogenital tissues
on the one hand and vascular tissue on the other. The
visceral and urogenital tissues contain a smoothelin
protein of 59 kDa. The main reactive protein in vas-
cular tissue showed as a 94kDa band in human, pig,
rabbit and dog. In addition, in these tissues a faint band
was observed at 59 kDa (Fig. 2). The 'heavy' isoform
of smoothelin is unlikely to be due to epitope-sharing
of two unrelated molecules. Recently, we generated
two newmonoclonal antibodies against recombinant
smoothelin. The epitopes recognized by these mono-
clonal anti-bodies differed from the one reacting with
R4A. However, they still recognized both isoforms (un-
published results).
The two forms of smoothelin are not transcripts of
two different genes. In situ hybridization on metaphase
spreads showed that only hybridizing loci are found on
both chromosomes 22 (Fig. 3). Southern blotting of gen-
omic human DNAdigested with a variety of endonucle-
ases and hybridized with the full size (for the visceral
form) human CDNAof smoothelin, showed banding
patterns as expected for a single copy gene (Fig. 3).
Localization of smoothelin. The localization of
smoothelin was investigated by immunohistology andimmunofluorescence microscopy. Previously, studies
on humantissue sections showed that in tissues no colo-
calization could be demonstrated of smoothelin and
Fig. 1. Double staining immunofluorescence microscopy of a small human muscular artery (a, b), human duodenum (c, d), human bladder (e,
f) and human arector pilli muscle (g, h). Sections were incubated with smoothelin monoclonal antibody R4A(a, c, e, g), rabbit desmin antiserum
(b, h) and rabbit keratin antiserum (d, f). Smoothelin and desmin display similar but not identical staining patterns, whereas smoothelin and ker-
atin are expressed in different tissues.
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Fig. 2. Immunoblotting of different tissues of several species. The
visceral tissues display a clear band at 59 kDa whereas the main band
for all the vascular tissues is at 94 kDa. With exception of the neonat-
al tissue all arteria also contain a little of the 59 kDa protein and dis-
play additional bands, likely due to some degradation of the tissue.
other SMCcomponents such as desmin, vimentin and
tubulin (36). Primary cultures of SMCof several hu-
mantissues, such as colon, arteria and uterus lost ex-
pression of smoothelin almost directly after culturing.
Whether this was due to an immediate blockage of
smoothelin gene transcription or selection of prolifera-
tive SMCduring the initial phase of culturing was un-
clear. However, presence of smoothelin was demon-
strated to be maintained in primary cell culture of cells
derived from a prostate epithelial cells. By immunohis-
tochemical staining it was demonstrated that the cells
contained desmin, smoothelin, vimentin and a-smooth
muscle actin (Fig. 4). The presence of the smoothelin
and desmin protein could be demonstrated for four pas-
sages. The concentration of smoothelin and desmin was
highest in the first passage and decreased gradualy dur-
ing subsequent passages. Also the number of smoothe-lin positive cells decreased during the following pas-
sages. No changes were observed in the expression of a-
smooth muscle actin and vimentin which were also
found in later (> 5) passages (data not shown). Smooth-
elin appeared to colocalize with or be attached to actin
stress fibers. Smoothelin synthesis appeared to be main-
tained in cells with a slender, spindle-like configuration,
but was lost in cells showing a more rounded or square
shape (Fig. 4).
DISCUSSION
Smooth muscle cells differ from striated, skeletal and
heart, muscle cells in structure, molecular composition
and contractile characteristics. The contractile appara-
tus of SMC is differently organized. The contractile
fibrils do not exhibit a sarcomeric repetitive structure,
as in striated mucle cells. In conjunction with this differ-
ence a number of structural or associated proteins in-
volved in the architecture of striated myofibrils, such as
titin and nebulin, are not found in SMC,whereas other
proteins such as metavinculin, SM22and calponin, are
almost exclusively found in SMC(10, ll, 12). It is ex-
pected that the differences in the structural organization
of SMC(versus striated cells) will be reflected in differ-
ences of the proteins used for its construction. Al-
though a number of SMCspecific proteins have been
identified and characterized, so far smoothelin and
smooth muscle myosin heavy chain SMI and SM2ap-
pear to be the only proteins, exclusively expressed in
(contractile) SMC (21, 36, 37).One of the obstructions in studying the localization
and function of smoothelin and its interaction with
other SMC components has been the lack of a cell
culture system in which smoothelin expression was
maintained. Only primary cell cultures from embryonic
chicken gizzard were occasionally observed to continue
smoothelin synthesis during the first passage (36). The
availability of primary cell cultures of cells derived
from humanbenign prostate hyperplasia that reproduci-
bly continue to synthesize smoothelin for a number of
passages will accelerate the investigation into the locali-
zation and the dynamics of interaction with other pro-
teins, and eventually will help to elucidate the function
of smoothelin. The data presented here provide an ex-
ample of the opportunities this system mayprovide.
The clear cytological colocalization of smoothelin with
actin in these humancells confirms the results previous-
ly obtained with primary cell cultures from embryonic
chicken gizzard (36). However, the prostate system can
also be used to study the fading of smoothelin in SMC
over a number of passages and its relation with contrac-
tility and organization of the contractile apparatus. In
addition, this system provides opportunities to test pro-
moter-deletion constructs of the smoothelin gene.
The full implications of the occurence of a second
(iso)form of smoothelin, that seems to be specific for
vascular SMCare not clear yet. In the view of recent
publications on SM22, dealing with distinct transcrip-
tional regulatory programs in vascular and visceral
SMC, this is an intriguing observation (20, 24). Here we
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Fig. 3 A: Southern blot of digested human genomic DNA. DNA is digested with SstI (1), SphI (2), Hindlll (3), Hindi (4) and BamHI (5). The
filter has been hybridized to a [32P] labeled smoothelin CDNAfragment bp 1-600. The probe hybridized only to one or two fragments. B: In situ
hybridization with a smoothelin cosmid probe. A signal is displayed in de chromosome spread (short arrows) as well as in the interphase nucleus
(long arrow).
report the presence of 'heavy' smoothelin in the vascu-
lar tissues of rabbit, pig, dog and men. Wehrens and co-
workers showed the presence 'heavy' smoothelin in
chicken and demonstrated that the increase in molecu-
lar weight is not due to dimer formation or association
with another SMCcomponent (Wehrens et al. in prepa-
ration). The two forms of smoothelin may be a mere
reflection of the embryonic origin of the SMC.SMCof
the visceral and urogenital tissues are considered to be
derived of cells of the mesodermal plate that migrate to
form the linings of the tracts of organs such as gut,
uterus and prostate (29). In these tissues the 59 kDa iso-
form of smoothelin is expressed. The origin of the SMC
aligning the vascular system is still under debate al-
though the hypothesis that these cells are recruited from
the direct surroundings of the vessels under influence of
factors produced by the endothelial cells, is now more
widely accepted (15, 16). In these cells the 94 kDa iso-
form of smoothelin is found. Four explanations can be
given for the occurence of two forms of smoothelin: 1)
two genes encode the two different forms; 2) alternative
splicing maybe responsable for a longer form of the
protein in the vascular tissue; 3) different transcription-
al regulation (dual promotor) in vascular and visceral
tissues; 4) differences in posttranslational modifications
mayinfluence the apparent molecular weight of the mol-
ecules. The first possibility has been ruled out. In situ
hybridization on metaphase spreads with a smoothelin
cosmid probe did not show any reproducable signal in
addition to the ones on chromosome22. This is more
extensively described in an in situ hybridization study
aimed at the assignment of the smoothelin gene to
chromosome22 and its position on the chromosome
(Engelen et al. , submitted). The FISH results corrobo-
rate those of the Southern blotting analysis revealing a
banding pattern which is in agreement with smoothelin
as a single copy gene in the humangenome. The choice
between the other three alternatives will need moreex-perimental evidence. However, considering the struc-
ture of the putative smoothelin deduced from the
known CDNAsequence an extensive posttranslational
modification, resulting in an apparent molecular weight
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Fig. 4. Second passage of a primary culture of benign prostate hyperplasia cells immunohistochemically stained with rabbit desmin antiserum
pDes (A), smoothelin monoclonal antibody R4A (B), and actin monoclonal antibody sm-1 (C). The staining pattern of R4A and sm-1 are similar
and differ of the one displayed after incubation with desmin antiserum. Not all cells react.
increase of more than 50%, seems to be unlikely. There-
fore, future research will focus on the second and third
alternative.
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